Simvastatin Differentially Modulates Glial Functions in Cultured Cortical and Hypothalamic Astrocytes Derived from Interferon α/β Receptor Knockout mice

• Published in: Neurochemical research 2024-03, Vol.49 (3), p.732-743
• Main Authors: Bobermin, Larissa Daniele, Sesterheim, Patrícia, da Costa, Daniele Schauren, Rezena, Ester, Schmitz, Izaviany, da Silva, Amanda, de Moraes, Aline Daniel Moreira, Souza, Diogo Onofre, Wyse, Angela TS, Leipnitz, Guilhian, Netto, Carlos Alexandre, Quincozes-Santos, André, Gonçalves, Carlos-Alberto
• Format: Article
• Language: English
• Subjects: Anti-inflammatory agents; Astrocytes; Biochemistry; Biomedical and Life Sciences; Biomedicine; Cell Biology; Central nervous system; Cholesterol; Cyclooxygenase-2; Cytokines; Down-regulation; Extracellular levels; Gene expression; Genes; Glutamate-ammonia ligase; Glutamine; Glutathione; Hypothalamus; Inflammation; Interferon; Interleukin 10; Interleukins; Neurochemistry; Neurology; Neurosciences; NF-κB protein; Original Paper; Parameters; Receptors; Simvastatin; SIRT1 protein; Synaptic plasticity; Tumor necrosis factor-TNF; Tumor necrosis factor-α; α-Interferon
• ISSN: 0364-3190; 1573-6903; 1573-6903
• DOI: 10.1007/s11064-023-04073-w

Astrocytes have key regulatory roles in central nervous system (CNS), integrating metabolic, inflammatory and synaptic responses. In this regard, type I interferon (IFN) receptor signaling in astrocytes can regulate synaptic plasticity. Simvastatin is a cholesterol-lowering drug that has shown anti-inflammatory properties, but its effects on astrocytes, a main source of cholesterol for neurons, remain to be elucidated. Herein, we investigated the effects of simvastatin in inflammatory and functional parameters of primary cortical and hypothalamic astrocyte cultures obtained from IFNα/β receptor knockout (IFNα/βR −/− ) mice. Overall, simvastatin decreased extracellular levels of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), which were related to a downregulation in gene expression in hypothalamic, but not in cortical astrocytes. Moreover, there was an increase in anti-inflammatory interleukin-10 (IL-10) in both structures. Effects of simvastatin in inflammatory signaling also involved a downregulation of cyclooxygenase 2 (COX-2) gene expression as well as an upregulation of nuclear factor κB subunit p65 (NFκB p65). The expression of cytoprotective genes sirtuin 1 (SIRT1) and nuclear factor erythroid derived 2 like 2 (Nrf2) was also increased by simvastatin. In addition, simvastatin increased glutamine synthetase (GS) activity and glutathione (GSH) levels only in cortical astrocytes. Our findings provide evidence that astrocytes from different regions are important cellular targets of simvastatin in the CNS, even in the absence of IFNα/βR, which was showed by the modulation of cytokine production and release, as well as the expression of cytoprotective genes and functional parameters.